Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2001, p. 3375-3386, Vol. 21, No. 10
Department of Biochemistry, Center in
Molecular Toxicology, and The Vanderbilt-Ingram Cancer Center,
Vanderbilt University School of Medicine, Nashville, Tennessee 37232
Received 17 November 2000/Returned for modification 29 January
2001/Accepted 9 February 2001
Downstream target genes of p53 are thought to mediate its
tumor-suppressive activity, but it is unknown whether differential transactivation of these genes is regulated at the level of p53 binding
to their promoters. To address this issue, p53 binding in vivo to
consensus sites in the p21Waf1, MDM2, and PIG3 promoters
was investigated in cells exposed to adriamycin (ADR) or ionizing
radiation as well as in an inducible p53 cell line. p53-DNA complexes
were cross-linked in vivo by treating the cells with formaldehyde and
processed by chromatin immunoprecipitation-PCR. This methodology
allowed for the analysis of relevant p53-DNA complexes by preventing
redistribution of cellular components upon collection of cell extracts.
Increased p53 binding to the p21Waf1, MDM2, and PIG3
promoters occurred within 2 h after p53 activation; however,
significant increases in PIG3 transcription did not occur until 15 h after p53 binding. Gel shift analyses indicated that p53 had lower
affinity for the consensus binding site in the PIG3 promoters compared
to its consensus sites in the p21 and MDM2 genes, which suggests that
additional factors may be required to stabilize the interaction of p53
with the PIG3 promoter. Further, acetylated p53 (Lys382) was found in
chemically cross-linked complexes at all promoter sites examined after
treatment of cells with ADR. In summary, the kinetics of p53 binding in
vivo to target gene regulatory regions does not uniformly correlate
with target gene mRNA expression for the p53 target genes examined. Our
results suggest that target genes with low-affinity p53 binding sites may require additional events and will have delayed kinetics of induction compared to those with high-affinity binding sites.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.10.3375-3386.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Kinetics of p53 Binding to Promoter Sites In
Vivo

*
Corresponding author. Mailing address: 652 Medical
Research Building II, The Vanderbilt Cancer Center, Nashville, TN
37232-6838. Phone: (615) 936-1512. Fax: (615) 936-1790. E-mail:
pietenpol{at}toxicology.mc.vanderbilt.edu.
Present address: National Center for Biotechnology Information,
National Institutes of Health, Bethesda, MD 20892.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|